Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
TAE Life Sciences Logo
TAE Life Sciences Growth Score
57
CB Rank
40596
Heat Score
67
TAE Life Sciences is an pre-clinical biotechnology company developing comprehensive biologically-targeted radiation therapy
Founded
obfuscation
PrivateSeries B Irvine, California, United States51-100 taelifesciences.com/
Biotechnology
Health Care
Life Science
Medical
Overview

TAE Life Sciences
Total Funding
obfuscation
Growth Score
57
Heat Score
67

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score57
-16 pts
in past quarter
Heat Score 67
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About TAE Life Sciences

CB Rank
40596
TAE Life Sciences is an pre-clinical biotechnology company developing comprehensive biologically-targeted radiation therapy
Founded
obfuscation
PrivateSeries B Irvine, California, United States51-100 taelifesciences.com/
Biotechnology
Health Care
Life Science
Medical

Funding Rounds

Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Sub-Organization of 
TAE Technologies Logo
TAE Technologies
Legal Name TAE Life Sciences, LLC
Also Known As TAE Life Sciences
Operating Status Active
Company Type For Profit
Founders  Bruce Bauer
About the Company

TAE Life Sciences is developing a novel biological-targeting radiation therapy based on Boron Neutron Capture Therapy (BNCT) to improve the lives of patients with rapidly spreading, invasive and recurrent cancers that do not respond to other cancer therapies. TLS is the only company with a comprehensive target drug and neutron technology product

portfolio to enable next-generation combination cancer therapy as a first-line treatment for patients globally.

Contact Email contact@taelifesciences.com
Predictions & Insights

Growth Insight

See this Growth Insight
TAE Life Sciences is
Lorem
 to be growing
Top Contributing Factors
Market Share Expansion

Growth Prediction

See this Growth Prediction

Products & Services

Boron Neutron Capture Therapy (BNCT)
A biologically targeted radiation therapy that uses boron-10 drugs and low-energy neutron beams to selectively destroy cancer cells while sparing healthy tissue.
Alphabeam™ Neutron System
An accelerator-based neutron source designed for in-hospital use to deliver low-energy neutron beams required for BNCT treatments.

Research & Development

TAE Life Sciences is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - TAE Life Sciences Logo
Series B - TAE Life Sciences
2
obfuscation
Artis VenturesSeries B
obfuscation
Series B - TAE Life Sciences Logo
Series B - TAE Life Sciences
2
obfuscation
Artis VenturesSeries B
obfuscation
Series B - TAE Life Sciences Logo
Series B - TAE Life Sciences
2
obfuscation
Artis VenturesSeries B
obfuscation
Series B - TAE Life Sciences Logo
Series B - TAE Life Sciences
2
obfuscation
Artis VenturesSeries B
obfuscation
Series B - TAE Life Sciences Logo
Series B - TAE Life Sciences
2
obfuscation
Artis VenturesSeries B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - TAE Life Sciences Logo
Series B - TAE Life Sciences
2
obfuscation
Artis VenturesSeries B
obfuscation
Series B - TAE Life Sciences Logo
Series B - TAE Life Sciences
2
obfuscation
Artis VenturesSeries B
obfuscation
Series B - TAE Life Sciences Logo
Series B - TAE Life Sciences
2
obfuscation
Artis VenturesSeries B
obfuscation
Series B - TAE Life Sciences Logo
Series B - TAE Life Sciences
2
obfuscation
Artis VenturesSeries B
obfuscation
Series B - TAE Life Sciences Logo
Series B - TAE Life Sciences
2
obfuscation
Artis VenturesSeries B

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 3 Board Members and Advisors 2 Contacts 67

Employee Profiles

Board Members and Advisors

News

News and Press

News•Apr 8, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 18, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 16, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 15, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,249
-76.56%
 in past month

IT Spend

$362.3KThis year, TAE Life Sciences is projected to spend $362.3K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Fierce Pharma Logo
Fierce Pharma
93
Row-Based Cooling Logo
Row-Based Cooling
89
AT&T Content and Entertainment Logo
AT&T Content and Entertainment
89

Active Website Tech Count

16TAE Life Sciences is actively using 16 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.

Total IP

20The intellectual property of TAE Life Sciences includes 16 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, TAE Life Sciences has registered 4 trademarks with the most popular class being 'Medical apparatus and instruments', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is TAE Life Sciences's headquarters? TAE Life Sciences is located in Irvine, California, United States.Who invested in TAE Life Sciences? TAE Life Sciences has 2 investors including Artis Ventures and  Big Sky Partners.When was the last funding round for TAE Life Sciences? TAE Life Sciences closed its last funding round on
obfuscation
from a Series B round.Who are TAE Life Sciences's competitors? Alternatives and possible competitors to TAE Life Sciences may include STELLA PHARMA, Sumitomo Heavy Industries, and  Shimadzu.How much funding has TAE Life Sciences raised to date? TAE Life Sciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|